ChemicalBook >> CAS DataBase List >>Nesvacumab

Nesvacumab

Nesvacumab structure

CAS No.: 1296818-77-3

Chemical Name:: Nesvacumab

Synonyms: Nesvacumab;Research Grade Nesvacumab(DHA42303)

CBNumber:: CB18080874

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

Last updated:2024-07-02 08:55:01

Request For Quotation

Nesvacumab Properties

form	Liquid
color	Colorless to light yellow
FDA UNII	WX8293WGLC
NCI Drug Dictionary	nesvacumab

Nesvacumab Chemical Properties,Uses,Production

Biological Activity

Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema.

Nesvacumab Preparation Products And Raw materials

Raw materials

Preparation Products

Nesvacumab Suppliers

Global( 7)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8014	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1565	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10351	58
Biolab Reagents	027-65279366 18162686757	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5731	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11975	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	313359644@qq.com	China	3263	58

Supplier	Advantage
ShangHai Biochempartner Co.,Ltd	62
Guangzhou Hongyuan Chemical Co.,Ltd	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Changsha Fuzhen Biotechnology Co.，LTD	58

1296818-77-3(Nesvacumab)Related Search:

Urelumab varlilumab Eptinezumab Atezolizumab Obinutuzumab

Sutimlimab Utomilumab Glofitamab Odronextamab Rituximab

1of2

Nesvacumab Research Grade Nesvacumab(DHA42303) 1296818-77-3